Direct-to-consumer acquisition eventually reaches a ceiling in this category, while true scale comes through channel: health plans, employers, providers, and pharmacies that can deliver eligible members in bulk. But channel marketing is a distinct discipline with unique enablement needs and long sales cycles. We create the partner strategy and go-to-market that transform these relationships into a durable, low-cost acquisition engine.
The Challenge
Your direct-to-consumer CAC continues to rise, and channel is the only path beyond the ceiling
In diabetes and cardiometabolic, the eligible population is concentrated inside health plans and employer benefits programs, and pure direct-to-consumer acquisition gets more expensive as you exhaust the reachable audience. Companies that stay DTC-only hit a growth ceiling and watch blended CAC climb. The members you want are already gathered by payers and employers, and failing to build the channel to reach them there leaves your cheapest, most durable growth completely untapped.
You approach channel as a sales problem when it requires marketing and enablement
Landing a payer or employer contract is only the start; the partner then has to actually drive enrollment among their members, and that requires co-marketing, member communications, and enablement most cardiometabolic companies never build. Deals get signed and then underperform because no one equipped the partner to promote the program. The gap between a signed contract and a channel that delivers members is a marketing gap, and teams that treat it as purely a sales handoff watch their partnerships stall.
Every channel has different buyers and economics, but you are treating them the same
Payers, employers, providers, and pharmacies each have distinct decision-makers, sales cycles, incentives, and member-activation dynamics, yet many companies approach channel with a single generic playbook. A message that lands with an employer benefits leader falls flat with a provider, and the enablement a pharmacy needs looks nothing like what a health plan requires. Without a channel-specific strategy, you spread effort thinly across partners and convert none of them well.
You cannot determine channel contribution, so you cannot know where to invest
Channel acquisition runs through partners' systems and long cycles, making attribution genuinely hard, and companies without a measurement approach fly blind on which partners and channels actually produce activated members. That means investment decisions get made on relationship optics rather than performance. When you cannot see which channel delivers durable members at what cost, you keep pouring effort into partners that look impressive and starve the ones quietly driving real enrollment.
How We Support You
We begin by determining which channels truly fit your business and in what sequence – payer, employer, provider, pharmacy – based on where eligible members are concentrated and which partners you can realistically win and activate. Channel consists of several motions, not one, so we prioritize instead of spreading you thin and shape the strategy around each channel's specific economics and decision-makers.
Next, we develop the go-to-market for priority channels, viewing the signed contract as the starting point rather than the finish line. This includes the co-marketing, member communications, and partner enablement that drive enrollment within a partner's population, because a deal that no one can effectively promote will quietly underperform. Most cardiometabolic companies overlook this enablement layer, yet it is what converts a logo on a slide into members.
We adapt the approach to the realities of every channel. We create separate playbooks for the employer benefits buyer, health plan, provider, and pharmacy, aligned with their incentives, cycles, and member-activation dynamics – giving each partner a motion built around how they actually decide and how their members truly enroll. Generic channel marketing fails because these audiences are simply not interchangeable.
We establish channel measurement so you can understand contribution and direct investment accordingly. We design attribution that functions across partner systems and extended cycles, measuring not only signed deals but activated members by channel, so performance guides investment rather than relationship optics. Making channel understandable allows you to double down on what works and eliminate what does not.
What sets us apart is that we build channel as operators who integrate it with your entire go-to-market, rather than as a business-development team pursuing signatures. We connect partner marketing with your growth strategy, enablement, and measurement so channel becomes a durable, low-cost acquisition engine, and we judge it by activated members delivered, not deals announced.
What we deliver
- A prioritized channel strategy across payer, employer, provider, and pharmacy
- Go-to-market and enablement that drive enrollment after the deal is signed
- Channel-specific playbooks matched to each partner's economics and buyers
- Co-marketing and member communications that activate partner populations
- Channel attribution tracking activated members, not just signed contracts
In cardiometabolic, signing an employer or payer is the easier half. Channel pays off only when you equip the partner to enroll its members – and that enablement is a marketing responsibility most companies never staff.
Our Methodology
We lead a channel engagement designed for cardiometabolic's concentrated, multi-partner landscape. The first phase focuses on prioritization: we identify where eligible members concentrate, evaluate which channels you can win and activate, and sequence them instead of chasing all of them simultaneously. Channel involves several distinct motions, and choosing the right one first is most of the battle.
The second phase covers go-to-market and enablement for the priority channel. We develop the channel-specific playbook, co-marketing, and partner enablement needed to generate enrollment after contract signature, because channels most often fail in the post-signature gap. This work is what transforms a partnership into members.
The last phase centers on measurement and scaling. We implement attribution that measures activated members by channel across partner systems and long cycles, then direct investment toward what performs. Unlike a business-development firm that tallies signed deals, we hold channel accountable for activated members delivered and link it to your broader go-to-market, because a signed logo that enrolls no one does not represent growth.
Our Approach
During the first thirty days, we prioritize channels and create the go-to-market for the first one, giving you within weeks a clear sequence and a playbook for the channel most likely to deliver eligible members. Prioritization by itself usually shifts effort away from partners that appear impressive but will not activate.
In the middle of the engagement, we develop enablement, co-marketing, and member communications while establishing channel attribution. Your team includes a channel operator with go-to-market support; on your side, we require executive sponsorship for partner relationships and access to the owners of partnerships and enrollment data. Winning and activating channel partners requires leadership at the table, not only a marketer.
In the final phase, we validate the channel with a live partner, assess activated-member contribution through the new attribution, and determine where to invest next. We maintain a working cadence for partner enablement and provide a monthly readout centered on activated members by channel rather than signed deals.
Engagements generally last four to six months, longer than building a digital channel because partner cycles are lengthy and enablement needs time to produce enrollment. By the end, you have a prioritized channel strategy, a validated enablement motion, and the measurement needed to invest behind it – the groundwork for a durable, low-cost acquisition engine.
- Access to concentrated eligible members via channel
- Partners enabled to actually drive enrollment
- Channel-specific motions that convert each partner type
- Investment guided by activated-member contribution
If your diabetes & cardiometabolic health company needs partner & channel marketing leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What is the cost of a partner and channel marketing engagement for a cardiometabolic company?
The engagement has a fixed monthly fee for the four-to-six-month build, far below the cost of a full channel team and supported by the lower long-term CAC channel provides compared with rising direct-to-consumer costs. The primary cost driver is the number of channels pursued and the complexity of enablement required by each partner. We scope fees around priority channels instead of attempting to build everything simultaneously.
How quickly can we expect results from channel marketing?
Channel follows a longer curve than digital because enablement and partner cycles require time, meaning significant activated-member volume usually emerges over several months, not weeks. Strategy and enablement create value sooner by concentrating effort and properly equipping partners. We establish that expectation from the outset because channel is a durable, long-term engine rather than a quick-acquisition switch.
How does the channel team collaborate with our current partnerships and sales staff?
We create the marketing and enablement layer that surrounds your sales and partnership efforts rather than replacing them, preparing partners to generate enrollment once deals are signed. We require executive sponsorship for those relationships, access to the partnership owner, and enrollment data for measuring contribution. The motion is built for your team to operate, allowing channel to continue producing after the engagement concludes.
How is Winston Francois different from a channel sales or business development agency?
A business-development firm counts signed contracts and then hands them off; we create the enablement and co-marketing that convert those agreements into enrolled members, while measuring activated-member contribution. We also develop distinct motions for payers, employers, providers, and pharmacies rather than applying a single generic playbook. The result is a durable acquisition engine connected to your go-to-market, not a collection of announced deals that quietly underperform.
How is ROI on channel marketing measured?
We track the activated members delivered through each channel, along with their cost and durability, using attribution built to function across partner systems and extended cycles. This means measuring beyond the signed deal through actual enrollment and retention in each partner's population. Since the objective is a lower long-term CAC than direct-to-consumer, ROI is evaluated by the cost and quality of members channel generates over time.
How do you tailor your approach to payers, employers, and providers?
Each channel has unique decision-makers, incentives, sales cycles, and member-activation dynamics, so we create an individual playbook for each instead of recycling one message. An employer benefits leader, health plan, provider, and pharmacy each make decisions and activate differently, and each also requires different enablement. Aligning the motion with a channel's actual economics is precisely what a generic approach cannot accomplish.
What kind of cardiometabolic company is best suited to this service?
The ideal fit is a diabetes or cardiometabolic company with a proven product and direct funnel that is now reaching a DTC ceiling or seeking the lower CAC channel provides. If you have not validated that members activate and retain, channel will merely scale a leaky funnel. This engagement is for companies whose eligible members are concentrated in payer and employer populations they cannot reach directly.
